跳至主要内容
临床试验/NCT07319208
NCT07319208招募中3 期

Efficacy of Early Continuous Infusion of Hypertonic Saline Solution on the Neurological Outcome at 6 Months in Traumatic Brain Injured Patients. A Single-blinded, Multicenter, Randomized, Controlled Clinical Trial With Blinded Evaluation of the Primary Outcome.

Nantes University Hospital48 个研究点 分布在 1 个国家目标入组 760 人开始时间: 2026年4月21日最近更新:
干预措施

试验速览

阶段
3 期
状态
招募中
入组人数
760
试验地点
48
主要终点
Efficacy of early continuous of HSS

研究概览

简要总结

The purpose of this study is to demonstrate the efficacy of early continuous intravenous infusion of hypertonic saline solution (HSS) to improve survival and independence in daily life activities (at 6 months) of patients with traumatic brain injury at high risk of intracranial hypertension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient admitted to intensive care unit
  • Traumatic brain injury with Glasgow Coma Scale ≤ 12
  • Intracranial pressure (ICP) monitoring based on the attending physician's clinical judgment, in accordance with guidelines or clinical/radiological signs considered at risk of intracranial hypertension
  • Inclusion during the first 12 hours after Intracranial pressure monitoring placement
  • Informed and signed consent
  • National health insurance

排除标准

  • Glasgow Coma Scale (score = 3) and persistent abnormal pupillaryreactivity despite urgent therapy
  • Associated cervical spinal cord injury
  • Imminent death and do-not-resuscitate orders
  • Coma secondary to cardiac arrest
  • Pregnancy (serum or urine test performed in routine care)
  • Severe Cardiac insufficiency
  • Severe chronic renal insufficiency
  • Severe hepatic insufficiency: patient presenting with oedemato-ascitic decompensation of liver cirrhosis or patient with Child-Pugh class C cirrhosis
  • High risk of follow-up difficulties after ICU discharge
  • Patients under court protection
  • Patient who does not speak French

研究组 & 干预措施

Hypertonic Saline Solution

Experimental

Continuous infusion of HSS (NaCl 20%) for 48 hours (can be prolonged during the period of intracranial hypertension)

干预措施: Hypertonic saline solution (Drug)

Standard

No Intervention

Standard of care

结局指标

主要结局

Efficacy of early continuous of HSS

时间窗: 6 months

Rate of moderate to no dependency in activities in daily living at 6 months is defined as a Barthel Index of independence in activities in daily living ≥ 61.

Efficacy of early continuous of HSS

时间窗: 3 months

Survival : number of patients still alive

次要结局

  • Quality of life(until 12 months)
  • Neurological recovery(until 12 months)
  • Anterograde amnesia(until 6 months)
  • Neurocognitive functioning(6 months)
  • Cost-effectiveness analysis(12 months)
  • Neurological outcome(6 months)
  • Genetic biomarkers(12 months)
  • Treatment of intracranial hypertension(7 days)
  • Tolerance(1 month)
  • Neurological recovery(7 days)
  • Quality of life(until 12 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (48)

Loading locations...

相似试验